Article Details
Retrieved on: 2022-04-07 17:01:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Biotechnology, Phase I/II, Complement C5 inhibitors; Complement C5a inhibitors, Intravenous. Vilobelimab, InflaRx, Phase II ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here